Bixa orellana L. by-products’ fractions from an industrial process: antiproliferative activity on tumor cells and chemical profile
Authors:
- 4 October 2020
- journal article
- research article
- Published by Taylor & Francis in Natural Product Research
- Vol. 35 (24) , 6106-6111
Abstract
This study evaluated the phytochemical characterization of Bixa orellana (BO extract) unsaponifiable extract and resulting fractions (F fraction - FF, Geranyl fraction – GF and R fraction- RF) obtained as by-products of an industrial process investigating in vitro antiproliferative activities in human tumoral cells. The main compounds identified by GC-MS for BO extract were Geranylgeraniol (61.51%); for FF: Geranylgeraniol (70.23%); for GF: Geranylgeraniol (78.92%) and for RF: β-cubebene (27.75%). Quantifications of geranylgeraniol by GC-FID presented the percentage content: BO 27.52%; FF 38.52%; GF 51.44% and RF 1.81%. BO extract showed a significant antiproliferative activity, with GI50 up to 4 µg/mL. All fractions had a remarkably similar antiproliferative activity profile (GI50 27-47 µg/mL). Data reported herein showed an important cytostatic effect for BO extract, nevertheless this activity is not attributed exclusively to geranylgeraniol. In conclusion, this by-product becomes of great value, being a potential candidate for development of new anti-tumor ingredients. Graphical AbstractKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (#2018/20252-8, #2015/08600-2)
This publication has 15 references indexed in Scilit:
- Effect of bixin on DNA damage and cell death induced by doxorubicin in HL60 cell lineHuman & Experimental Toxicology, 2016
- Phytochemistry, biological activities and potential of annatto in natural colorant production for industrial applications – A reviewJournal of Advanced Research, 2016
- Induction of apoptosis by apocarotenoids in B16 melanoma cells through ROS-mediated mitochondrial-dependent pathwayJournal of Functional Foods, 2016
- Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast CancerPLOS ONE, 2013
- Terpenic fraction of Pterodon pubescens inhibits nuclear factor kappa B and extracellular signal-regulated protein Kinase 1/2 activation and deregulates gene expression in leukemia cellsBMC Complementary and Alternative Medicine, 2012
- Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cellsToxicology, 2010
- Characterization of different annatto extracts based on antioxidant and colour propertiesLWT, 2008
- Terpenoids and breast cancer chemopreventionBreast Cancer Research and Treatment, 2008
- Double-blind randomized placebo-controlled study of bixa orellana in patients with lower urinary tract symptoms associated to benign prostatic hyperplasiaInternational braz j urol, 2007
- Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancerNature Reviews Cancer, 2007